Please provide your email address to receive an email when new articles are posted on . Heron Therapeutics announced FDA approval of its prior approval supplement application for the Zynrelef vial ...
Demonstration of the vial solution being transferred to the needle that will be used for injection into the tumour sites of patients with recurrent glioblastoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results